|
Association between insurance plan, prior authorization, and time to receipt of oral anticancer drugs. |
|
|
No Relationships to Disclose |
|
Melissa Parsons Beauchemin |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Charter Oak Research; Deerfield Management; Enterprise Analysis Corporation; ExpertConnect; Incrowd; M3; M3 (I); Massive Bio; MDoutlook; Medpanel; Medscape; Medscape; medsurvey; OCN; Sermo; Sermo (I) |
Other Relationship - Onclive |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Clovis Oncology |
Research Funding - Merck (Inst) |
Patents, Royalties, Other Intellectual Property - UpToDate |
|
|
Consulting or Advisory Role - AIM Specialty Health |